CQP(SZ:000950)2023-05-29 08:26Group 1: Strategic Planning - The company's "14th Five-Year" strategic plan aims for a sales scale exceeding 100 billion yuan, driven by both organic growth and external expansion [2] - The plan includes completing layouts in 300 cities across the country, focusing on integrated retail and wholesale, product diversification, and business digitization [2] Group 2: Digital Business Development - The company emphasizes digital transformation, investing in various management systems such as ERP and WMS to enhance operational efficiency [3] - It has established its own e-commerce platform, "Zhongyao Cloud Business," providing 24-hour one-stop procurement services and online health services [3] Group 3: Accounts Receivable Risk Management - The company acknowledges the high accounts receivable typical in the pharmaceutical industry, primarily from public hospitals, but considers the repayment risk to be low [3] - Measures have been implemented to strengthen accounts receivable management and improve cash flow from operations [3] Group 4: Financial Cost Management - The company currently relies heavily on debt financing, resulting in high financial costs, with plans to optimize its financing structure to reduce these costs [3] Group 5: Mergers and Acquisitions - Previous investments and acquisitions during the "13th Five-Year" period have yielded positive results, with future plans to accelerate national network layout in line with the "300 Cities" strategy [3]